BioSig’s Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota

December 18, 2020

BioSig Achieves First Commercial Sale of Three PURE EP Systems

December 11, 2020

BioSig CEO Kenneth L. Londoner to Present at the 13th Annual LD Micro Main Event Conference

December 10, 2020

BioSig to Highlight PURE EP™ System at the Benzinga Global Small Cap Conference

December 3, 2020

BioSig’s PURE EP System to Support Live Patient Cases during EPLive 2020

November 30, 2020

BioSig to Host Business Update Conference Call on November 18, 2020

November 12, 2020

BioSig Announces Completion of PURE EP™ System Installation at New Medical Center

October 29, 2020

BioSig Issues October 2020 Shareholder Update Letter

October 28, 2020

ViralClear halts its Phase 2 Hospitalized COVID-19 Trial

October 26, 2020

SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST COVID-19

September 30, 2020